Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: milestone / Re: lambertslunatics:

Dec 21, 2007 07:06PM
7
Jul 29, 2009 04:47PM
4
Jul 29, 2009 09:12PM
7
Jul 30, 2009 02:24PM
2
Jul 30, 2009 03:18PM
4
Jul 30, 2009 05:14PM
6
Jul 31, 2009 01:12AM

"A perpetual victim of circumstance mentality" would have nothing to do with ex parte validity challenges and waiting for a USPTO determination, would it?

Perhaps a savvy BoD would have recognized that such challenges and obstacles lied ahead, and approached heavy hitters to accept offers in an auction-like manner for this most-prized asset and monetized its entire value using a discounted cash flow method and moved on with ample funding for our newfound business ventures, as opposed to devising and entering into an agreement that is apparently less than perfect, of significant cost, and subjects the company and its shareholders to extraordinarily lengthy legal processes and the risky whims of those involved in such processes and other factors beyond our control. One can say the BoD is a victim of exparte validity challenges and USPTO actions, but that would only be applicable to a 'caretaker' type BoD, apparently what we have.

What we need to be about is the proper strategy and management for maximizing the value of our most valuable and only profitable asset. What do you really know about it?

4
Jul 31, 2009 01:51PM
Share
New Message
Please login to post a reply